| Literature DB >> 23190493 |
Antonio Tartaglione1, Luciano Spadavecchia, Marco Maculotti, Fabio Bandini.
Abstract
BACKGROUND: To investigate to what extent Alzheimer's Disease (AD) affects Resting State activity, the possible impairment of independent electrophysiological parameters was determined in Eye-open and Eye-closed Conditions. Specifically, Flash-Visual Evoked Potential (F-VEP) and quantitative EEG (q-EEG) were examined to establish whether abnormalities of the former were systematically associated with changes of the latter.Entities:
Mesh:
Year: 2012 PMID: 23190493 PMCID: PMC3527189 DOI: 10.1186/1471-2377-12-145
Source DB: PubMed Journal: BMC Neurol ISSN: 1471-2377 Impact factor: 2.474
Figure 1F-VEPs recorded in an AD-AL patient from left (A) and right (B) eye were averaged from 4 separate blocks of 64 trials. In A the distribution of components within waveform are presented. Latency of P2, as shown in B, is the parameter taken into account in the study.
F-VEP - Means and standard errors of P2 latency
| EYE-OPEN (EO) | 136,7 ± 3,6 | 132,5 ± 3,1 |
| EYE-CLOSED (EC) | 140,4 ± 3.1 | 145,7 ± 3,9 |
| EC – EO | 3,7 ± 2,6 | 13,2 ± 2,2 |
Means ± Standard Errors of P2 latencies and of their difference between Eye-closed (EC) and Eye-Open (EO) Conditions. Controls are compared with all the AD patients.
F-VEP - Means and standard errors of P2 latency
| EYE-OPEN (EO) | 136,7 ± 3,6 | 131,3 ± 4,5 | 133,5 ± 4,6 |
| EYE-CLOSED (EC) | 140,4 ± 3.1 | 137,2 ± 4,6 | 153,4 ± 5,1 |
| EC – EO | 3,7 ± 2,6 | 5,8 ± 2,3 | 19,9 ± 1.8 |
Means ± Standard Errors of P2 latencies and of their difference between Eye-closed (EC) and in Eye-Open (EO) Conditions. AD patients are split into AD-NL and AD-AL groups.
Figure 2Distribution of individual A/SW Ratios as a function of Groups and Resting Conditions.
- Means and standard errors of A /SW ratios in different groups and rest conditions
| CONTROL | 0,7 ± 0,1 | 2,5 ± 0,4 | Z: -2,93; N=11; P<0,01 |
| AD-NL | 1,4 ± 0,7 | 2,7 ± 1,2 | Z: -2,31; N=9 P<0,05 |
| AD-AL | 0,4 ± 0,1 | 0,5 ± 0,1 | Z: -0.25; N= 10; ns |
| K-W: 3,53; df: 2; ns | K-W: 12,12; df: 2; P<0,01 |
A/SWs are averaged throughout channels. In A, Z-scores refer to the Wilcoxon rank test of A/SW Ratio difference between Conditions within Group. K-Ws refer to the Kruskal-Wallis Analysis of Variance of A/SW differences among Groups within Condition.
- Means and standard errors of RPs for single frequency components in different groups and rest conditions
| CONTROL | alpha | 24,3 ± 2,8 | 44,5 ± 2,8 |
| beta | 36,1 ± 3,9 | 29,4 ± 3,9 | |
| delta | 21,4 ± 2,1 | 10,9 ± 1,0 | |
| theta | 18,2 ± 2,2 | 15,2 ± 2,2 | |
| AD-NL | alpha | 26,0 ± 5,2 | 38,6 ± 7,9 |
| beta | 28,1 ± 2,6 | 23,0 ± 3,2 | |
| delta | 24,9 ± 4,5 | 19,8 ± 5,6 | |
| theta | 21,0 ± 2,9 | 18,6 ± 3,8 | |
| AD-AL | alpha | 19,4 ± 3,4 | 20,5 ± 3,7 |
| beta | 29,8 ± 3,8 | 28,4 ± 4,1 | |
| delta | 26,6 ± 3,5 | 28,1 ± 4,1 | |
| theta | 24,2 ± 3,4 | 23,0 ± 3,8 |
RPs are averaged throughout channels.
Analysis of Condition * Component * Group interaction
| 0,05 | 2 | 0,03 | 0,77 | 0,47 | |
| Error A | 0,89 | 27 | 0,03 | | |
| 2,78 | 3 | 0,93 | 1,87 | 0,14 | |
| Error B | 40,18 | 81 | 0,5 | | |
| 0,06 | 2 | 0,03 | 1,36 | 0,27 | |
| Error A | 0,59 | 27 | 0,02 | | |
| 16,68 | 3 | 5,56 | 7,06 | < 0,01 | |
| Error B | 63,78 | 81 | 0,79 | ||
Analysis of variance of LRPs with one between (Groups) and one within (Component) variables in Eye-Open (A) and in in Eye-closed (B) Conditions.
Figure 3Mean spectral profile of the different Groups of patients observed in Eye-open (A) and in Eye-closed (B) Conditions.
Clinical data
| Age (years | 67,9 ± 4,9 | 70,1 ± 2,7 | 70,7 ± 6,3 |
| Schooling (years) | 6,18 ± 1,8 | 5,6 ± 3,3 | 7,2 ± 3,9 |
| Sex (N. women) | 5 | 4 | 4 |
| Symptom duration (months) | # | 13,2 ± 2,4 | 14,7 ± 2,2 |
| MMSE (corrected) | 26,3 ± 1,7 | 18 ± 2,6 | 15,8 ± 3,6 |
| DRS Verbal score (raw) | 72,4 ± 9,0 | 43 ± 7,0 | 37,7 ± 7,9 |
| DRS Non-verbal score (raw) | 55,9 ± 1,8 | 44,6 ± 6,7 | 45,7 ± 7,0 |
| DRS Total score (corrected) | 0,91 ± 0,06 | 0,63 ± 0,05 | 0,592 ± 0,06 |
Means ± SD of clinical parameters in the 3 Groups. Patients with “missing” P2 were excluded.